secwatch / observer
8-K filed May 29, 2026, 4:45 PM ET ticker STIM CIK 0001227636
other confidence high sentiment neutral materiality 0.15

Neuronetics stockholders elect all seven director nominees, approve 2026 equity plan at annual meeting

Neuronetics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuronetics, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-05-28 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-28
Exact text from the filing
Proposal 3: The approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2025 and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2025 was ratified by the Company’s stockholders by the votes set forth in the table below: 29,133,360 votes FOR the proposal 11,503,294 votes AGAINST the proposal 651,870 votes ABSTAIN 14,661,594 votes Broker Non-Votes
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuronetics, Inc. shareholders approved Approval of Neuronetics, Inc. 2026 Equity Incentive Plan at the 2026-05-28 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-05-28
Exact text from the filing
Proposal 4: The approval of the Neuronetics, Inc. 2026 Equity Incentive Plan was approved by the Company’s stockholders by the votes set forth in the table below: 23,802,955 votes FOR the proposal 16,651,661 votes AGAINST the proposal 833,908 votes ABSTAIN 14,661,594 votes Broker Non-Votes
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuronetics, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-28
Exact text from the filing
Proposal 2: The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the Company’s stockholders by the votes set forth in the table below: 47,194,967 votes FOR the proposal 6,924,816 votes AGAINST the proposal 1,830,335 votes ABSTAIN
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuronetics, Inc. shareholders approved Election of directors at the 2026-05-28 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-28
Exact text from the filing
Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2027 Annual Meeting, or until their respective successors are elected and qualified, by the votes set forth in the table below: Nominees For Withheld Broker Non-Votes Avinash N. Amin, M.D. 33,982,534 7,305,990 14,661,594 Robert A. Cascella 29,304,597 11,983,927 14,661,594 Sheryl L. Conley 29,304,311 11,984,213 14,661,594 Sasha S. Cucuz 28,512,554 12,775,970 14,661,594 Glenn P. Muir 29,281,048 12,007,476 14,661,594 Daniel L. Reuvers 34,472,656 6,815,868 14,661,594 Megan R. Rosengarten 28,794,454 12,494,070 14,661,594
View on SEC.gov

Browse all shareholder votes →

Neuronetics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-248525
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.